首页 > 市场调查报告书 > 製药

自体免疫疾病

市场调查报告书

商品编码

1304398

类风湿性关节炎(RA)诊断检验市场:检验各类型，各终端用户，各地区-市场规模，占有率，展望，机会分析，2023-2030年

Rheumatoid Arthritis Diagnostic Tests Market,Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test, Monitoring RA Treatment Efficiency Tests ), By End User, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月19日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

市场动态

主要市场参与者正专注于采用有机增长策略，例如推出类风湿关节炎诊断血液测试，这归因于全球类风湿关节炎诊断测试市场的增长。

本调查的主要特征

本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球类风湿性关节炎(RA)诊断检验市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球类风湿性关节炎(RA)诊断检验市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球类风湿性关节炎(RA)诊断检验市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球类风湿性关节炎(RA)诊断检验市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

企业简介
- Abbott Diagnostics(Abbott Laboratories)
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB,
- F.Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC(imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.

第9章章节

参考文献
调查手法

简介目录

Product Code: CMI3716

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease, which means that your immune system attacks healthy cells in your body by mistake, causing inflammation (painful swelling) in the affected parts of the body. RA mainly attacks the joints, usually many joints at once. RA commonly affects joints in the hands, wrists, and knees. In a joint with RA, the lining of the joint becomes inflamed, causing damage to joint tissue. This tissue damage can cause long-lasting or chronic pain, unsteadiness (lack of balance), and deformity (misshapenness).RA can also affect other tissues throughout the body and cause problems in organs such as the lungs, heart, and eyes.Rheumatoid arthritis is an autoimmune condition, which means it's caused by the immune system attacking healthy body tissue. The rheumatoid arthritis diagnostic tests market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally.

Market Dynamics

The key market players are focusing on adoption of growth organic strategies such launching of diagnostic blood test for rheumatoid arthritis, which is attributed to the growth of global rheumatoid arthritis diagnostic tests market. For instance, in March 2020, BD (Becton, Dickinson and Company) is a medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to rhumetoid arthritis in as little as 15 minutes test has been clinically validated at several hospitals and clinical laboratories in both the U.S. and China.

Key features of the study:

This report provides an in-depth analysis of the global rheumatoid arthritis diagnostic tests market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global rheumatoid arthritis diagnostic tests market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include include Abbott Diagnostics (Abbott Laboratories), Labcorp ,Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Augurex Life Sciences Corp., Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global rheumatoid arthritis diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market

Detailed Segmentation:

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
- Serology Test
  - Erythrocyte Sedimentation Rate (ESR)
  - Rheumatoid Factor (RF)
  - Anti-cyclic Citrullinated Peptide (anti-CCP)
  - Antinuclear Antibody (ANA)
  - Uric Acid
  - Other Tests
- Monitoring RA Treatment Efficiency Tests
  - Salicylate Level Count
  - Muscle Enzyme Tests (CPK, Aldolase)
  - Creatinine Test
Global Rheumatoid Arthritis Diagnostic Tests Market, By End User:
- Diagnostic Laboratories
- Private Laboratories
- Public Laboratories
- Ambulatory Surgical Centers
Global Rheumatoid Arthritis Diagnostic Tests, By Region:
- North America
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB
- F. Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC (imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
Key Developments
PEST Analysis

4. Global Rheumatoid Arthritis Diagnostic Tests Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Serology Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test

6. Global Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Private Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Public Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Rheumatoid Arthritis Diagnostic Tests Market, By Regions, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB,
- F.Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC (imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

类风湿性关节炎(RA)诊断检验市场:检验各类型，各终端用户，各地区-市场规模，占有率，展望，机会分析，2023-2030年